Strategies, needs and practices of Industry

If you wish to start inserting your own contributions, check out how to get started and the Wikia:Help:Introduction for usage and configuration support.

Working with industry

In this session industry representatives take the stand to tell us what they want from us. What are the tasks and responsibilities they want a TTO to assume – or what do they really don’t want us to interfere with? And what are the biggest mistakes we tend to make in their view?
Mette Kirstine Agger Presentation (ASTP members restricted access)
Danny Goderis Presentation (ASTP members restricted access)

Drug development: realistic versus idealistic

The road from an idea to a medicinal product is very long, and an extremely low percentage of ideas finally make it to the market: in a lot of cases it already goes wrong quite early because the concept of drug development is not very well understood in a university setting. What are the essential elements to take into account, and what are the obvious and less obvious pitfalls to avoid?
Jean-Marc Combette Presentation (ASTP members restricted access)

Food: from the farm (or the lab) to the fork

What is functional food, novel food, the European Food Safety Authority and a health claim? A basic knowledge on all these items (and more) is a prerequisite when you try to find a buyer or a licensee for whatever food ingredient. The second speaker will elaborate on genetically modified organisms: to what extent can you actually commercialize GM-food today, and what does it take to have it end upon your plate.
Gert-Jan Schaafsma Presentation (ASTP members restricted access)
Filip Knudde Presentation (ASTP members restricted access)

Medical devices: regulatory

Medical devices are subject to a quite different regulatory environment than drugs ... but not necessarily an easier one. Find your way through the complex system and learn all about CE Mark, Pre-market Approval, 510k, FDA, Notified Body, Quality Management System, etc.
Corinne Lebourgeois Presentation (ASTP members restricted access)

Medical devices: reimbursement

Regulatory issues are not the only hurdle to be overcome on its way to the market. Also the question whether the product will benefit from reimbursement by the national health authorities will determine on the level of interest of potential licensees. Can this be assessed beforehand? What are the steps to be taken in this respect and how can the process be optimized?
Corinne Lebourgeois Presentation (ASTP members restricted access)

Industry vs TTO patenting: divergent priorities

Do universities view IP in same way as major corporates? We don’t think so. Universities focus on the patent whereas companies focus on the product; patents being just one of the ’assets’ needed to make the product and defend against imitators. Is there something important to be learned from these radically different perspectives?
Snorre Kjesbu Presentation (ASTP members restricted access)
Jeremy Philpott Presentation (ASTP members restricted access)

Medical technologies

What are the issues that are really important for industry, and how do these issues influence their interaction with research institutions? How do they identify and acquire technology? What are their main business drivers and which elements determine their long and short term strategy? What do they expect from us? Decision makers from within five different sectors guide us through.
Frank Bistervels Presentation (ASTP members restricted access)
Federico Bilotti Presentation (ASTP members restricted access)


Telecommunications

The Telecom industry has undergone huge changes in the last few years. National monopolies are no more, physical networks have become commodities and the business model is being challenged by VOIP. In this new age what do the major telecoms companies need from the research base?
Keith Everard Presentation(ASTP members restricted access)
François Jamet Presentation (ASTP members restricted access)


Healthcare / Consumer products

The Healthcare sector is facing major challenges - development and regulatory costs are rising at a time when product pipelines are diminishing. They are seeking new technologies to achieve greater speed and efficiency and early screening – and alliances to fill pipelines. Universities are as important as ever but the way in which we engage will change.
Alan Lamont Presentation (ASTP members restricted access)
Robert Pinnock Presentation (ASTP members restricted access)


Information technology

The ICT ’industry’ moves very fast and is structured in such a way that makes it difficult to ‘digest’ university technologies. Moreover, IP is harder to protect since single patents offer little protection. Added to that, ‘killer applications’ are far from obvious. How then are we supposed to engage with the major ICT users?
Michel Benard Presentation (ASTP members restricted access)
Charles Irving Presentation (No presentation available)
Darko Piscevic Presentation (ASTP members restricted access)


Food and functional food industry

For a long time food had to be tasty, safe and reasonably priced. These days a major shift is ongoing towards functional food. How do evolutions towards convenience, shelf life and pre-biotics influence our interaction with industry? Is a new collaboration model required for the food of the future ?
Fillip Arnaut Presentation (ASTP members restricted access)
Ariane Andres Presentation (ASTP members restricted access)


Understanding Key Industries : Food and Medical devices

It is important to understand an industry before you can sell into it. In this session we hear from two very different industries – food and defence – and learn how they innovate and where the opportunities are for universities to collaborate and license their technologies.
Andrew Morgan Presentation (ASTP members restricted access)
Terry Fetterhoff Presentation (ASTP members restricted access)